Physician profile
Phoebe Carpenter
NPI 1639501489
$1,324.25
in general payments reported to CMS, 2019-2025
17 companies · $519 in 2025
The $519 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $201 · 2022: $227 · 2023: $293 · 2024: $83.63 · 2025: $519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $851 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $850.76 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $170.63 | 2021-2024 | Airsupra |
| Xeris Pharmaceuticals, INC. | $160.23 | 2023-2025 | Gvoke Hypopen |
| Bayer Healthcare Pharmaceuticals INC. | $151.73 | 2022 | |
| Glaxosmithkline, LLC. | $114.16 | 2021 | |
| Alnylam Pharmaceuticals INC. | $94.12 | 2023 | Givlaari |
| Beta Bionics, INC. | $88.03 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Insulet Corporation | $83.22 | 2025 | Omnipod |
| Lilly USA, LLC | $80.50 | 2025 | Zepbound, Mounjaro, Jardiance |
| Otsuka America Pharmaceutical, INC. | $76.74 | 2023 | Rexulti |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $75.60 | 2022 | |
| Cequr Corporation | $50.08 | 2025 | Cequr Simplicity |
| Exact Sciences Corporation | $40.99 | 2025 | Cologuard Collection Kit |
| Sequel Med Tech, LLC | $38.76 | 2025 | Twiist |
| Tandem Diabetes Care, INC. | $28.54 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Medtronic, INC. | $26.18 | 2025 | Minimed 780g |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $24.88 | 2025 | Korlym |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.86 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phoebe Carpenter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.